Home
/
Humacyte, Inc.
/
Financials
/
Quarterly
Humacyte, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Humacyte, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$753.0K
Nov 12, 2025
Q2
2025
Jun 30, 2025
$301.0K
Aug 11, 2025
Q1
2025
Mar 31, 2025
$517.0K
May 13, 2025
Q3
2025
Sep 30, 2024
$0
Nov 12, 2025
Q2
2025
Jun 30, 2024
$0
Aug 11, 2025
Q1
2025
Mar 31, 2024
$0
May 13, 2025
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($17.51M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($37.66M)
Aug 11, 2025
Q3
2025
Jun 30, 2025
($37.66M)
Nov 12, 2025
Q2
2025
Mar 31, 2025
$39.14M
Aug 11, 2025
Q3
2025
Mar 31, 2025
$39.14M
Nov 12, 2025
Q1
2025
Mar 31, 2025
$39.14M
May 13, 2025
Q3
2025
Sep 30, 2024
($39.20M)
Nov 12, 2025
Q3
2025
Jun 30, 2024
($56.66M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($56.66M)
Aug 11, 2025
Q2
2025
Mar 31, 2024
($31.90M)
Aug 11, 2025
Q3
2025
Mar 31, 2024
($31.90M)
Nov 12, 2025
Q1
2025
Mar 31, 2024
($31.90M)
May 13, 2025
Q3
2024
Sep 30, 2023
($26.00M)
Nov 8, 2024
Q2
2024
Jun 30, 2023
($22.71M)
Aug 13, 2024
Q3
2024
Jun 30, 2023
($22.71M)
Nov 8, 2024
Q1
2024
Mar 31, 2023
($36.97M)
May 13, 2024
Q2
2024
Mar 31, 2023
($36.97M)
Aug 13, 2024
Q3
2024
Mar 31, 2023
($36.97M)
Nov 8, 2024
Q3
2023
Sep 30, 2022
($25.28M)
Nov 9, 2023
Q3
2023
Jun 30, 2022
$36.87M
Nov 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($24.39M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($29.73M)
Aug 11, 2025
Q1
2025
Mar 31, 2025
($23.18M)
May 13, 2025
Q3
2025
Sep 30, 2024
($30.23M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($29.50M)
Aug 11, 2025
Q1
2025
Mar 31, 2024
($26.58M)
May 13, 2025
Q3
2024
Sep 30, 2023
($24.62M)
Nov 8, 2024
Q2
2024
Jun 30, 2023
($26.73M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($22.51M)
May 13, 2024
Q3
2023
Sep 30, 2022
($23.49M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($18.53M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($21.76M)
May 12, 2023
Q3
2022
Sep 30, 2021
($20.54M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($19.27M)
Aug 12, 2022
Q1
2022
Mar 31, 2021
($19.77M)
May 13, 2022
Q3
2021
Sep 30, 2020
($17.21M)
Nov 15, 2021